馃И Enzyme Launches Onyx
馃И Enzyme Launches Onyx
馃И Enzyme drops Onyx
Enzyme launches Onyx - a new platform designed for tokenizing investment strategies without infrastructure constraints.
After 8 years of development, the platform addresses key challenges:
- Full control over strategy structure and execution
- Cross-network asset management capabilities
- Flexible valuation mechanisms
Key features:
- Purpose-built for modern finance operators
- Enables fully tokenized strategy creation
- Works across multiple networks and protocols
The launch targets enterprises seeking freedom in decentralized asset management.
How to tokenize strategies without being locked into rigid infrastructure? How to have full control over structure, execution, and valuation? How to create strategies across networks, assets, & protocols without constraints? After hearing these questions for 8 years, we've
Enzyme.Myso Introduces Institutional-Grade Options for On-Chain Yield Generation
Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)
Tokenized Securities Market Projected to Reach $45T by 2030
Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)
Tokenized Real-World Assets Hit Major Milestone
Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)
Enzyme Acquires Myso Finance and Expands to Solana in Major 2024 Growth
Enzyme Protocol marked significant expansion in 2024 with key developments: - Acquired Myso Finance, the leading on-chain covered calls protocol - Invested in Trade Neutral to expand services to Solana ecosystem - Extended protocol to Arbitrum and integrated GMX - Launched first Advanced Automated Loops with Stader Labs - Reached $220M in Assets Under Technology with 1,400+ creations 2025 roadmap focuses on: - Completing Solana integration - Expanding to additional networks - Launching V5 protocol update - Strengthening global infrastructure position The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.